Search for: "Sanofi S A"
Results 81 - 100
of 924
Sorted by Relevance
|
Sort by Date
27 Nov 2015, 7:06 am
Federal Class-Action Suit Claims Sanofi Inflated Stock Prices Ponte claims that she was fired in 2014 in retaliation for reporting Sanofi’s kickback scheme. [read post]
29 Dec 2017, 4:01 pm
News this month on Sanofi's product Synvisc:Synvisc is an injected gel used for treating arthritis in knees. [read post]
10 Sep 2009, 9:59 pm
Sandoz, Inc.(1), arose as the result of ANDA filings by several Defendants for oxaliplatin, the active ingredient in Sanofi's Eloxatin ® colorectal cancer drug. [read post]
27 Aug 2019, 9:59 pm
The case arose in ANDA litigation involving Sanofi's Jevtana® (cabazitaxel), having the structure: where the methoxy... [read post]
13 Feb 2022, 6:12 pm
“Appeals court nixes Sanofi’s win in first Taxotere trial”: Barbara Grzincic of Reuters has this report on a ruling that the U.S. [read post]
5 Oct 2017, 3:28 pm
We affirm the districtcourt’s grant of Appellees’ JMOL of non-obviousness.Finally, we vacate the district court’s permanent injunction. [read post]
30 Aug 2010, 3:00 am
As we reported on August 3, Weil Gotshal is representing French drug make Sanofi in its bid for the Cambridge, Massachusetts-based biopharmaceutical company--Sanofi revealed an $18.5 billion offer on Sunday. [read post]
10 Oct 2011, 7:24 am
Para que no se vayan con la competencia de esa forma SANOFI ¿estaría limitando la innovación en el país? [read post]
15 Aug 2006, 6:45 am
It's also telling that Sanofi and Bristol made a lot of concessions to settle the patent litigation. [read post]
23 Jan 2012, 4:56 pm
” Despite these protections and Li’s promises, according to the government, starting sometime in or about October 2008, Li improperly accessed Sanofi’s internal database and began downloading Sanofi’s proprietary chemical structures. [read post]
30 Aug 2019, 12:45 pm
The decision was a loss for Amgen, which had claimed that Sanofi and Regeneron's drug Praluent infringed on its patents for the drug Repatha. [read post]
12 Jul 2011, 2:13 pm
" According to a July 11, 2011 Reuters news report by Ben Hirschler, "European regulators launch safety review of Sanofi’s Multaq": Analysts see Multaq, which won approval from European medicines regulators in September 2009 and was approved in the United States in July 2009, as an important driver for Sanofi to see it through patents expiries on multibillion-dollar drugs like the cancer treatment Taxotere and the blood thinner Plavix. [read post]
4 Feb 2011, 7:16 am
I've been following the proposed Genzyme-Sanofi deal with some interest since Sanofi first made its move since what seems like many months ago. [read post]
11 Nov 2017, 11:00 am
Sanofi v. [read post]
1 Aug 2011, 8:41 am
Justice Jagot has found – generously (to Sanofi-Aventis) – that Apotex’s proposed supply of a generic leflunomide product for the treatment of arthritis would infringe the psoriasis treatment patent, and that Sanofi-Aventis is thus entitled to an injunction preventing such supply. [read post]
27 Jul 2010, 4:55 am
’s (“Sandoz’s”) ANDA No. 77-857 for a generic version of Sanofi’s blockbuster anti-coagulant drug LOVENOX (enoxaparin sodium injection). [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
19 Jun 2007, 8:21 am
Sanofi-Synthelabo et al. v. [read post]
